Discovery of a Biomarker Signature That Reveals a Molecular Mechanism Underlying Diabetic Kidney Disease via Organ Cross Talk
Diabetes Care
.
2022 Jun 2;45(6):e102-e104.
doi: 10.2337/dc22-0145.
Authors
I-Wen Wu
1
2
3
,
Tsung-Hsien Tsai
4
,
Chi-Jen Lo
5
,
Yi-Ju Chou
6
,
Chi-Hsiao Yeh
2
3
7
,
Mei-Ling Cheng
5
8
9
,
Chi-Chun Lai
2
3
10
,
Huey-Kang Sytwu
11
12
,
Ting-Fen Tsai
6
13
14
Affiliations
1
Department of Nephrology, Chang Gung Memorial Hospital, Keelung, Taiwan.
2
Community Medicine Research Center, Chang Gung Memorial Hospital, Keelung, Taiwan.
3
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
4
Advanced Tech BU, Acer Inc., New Taipei City, Taiwan.
5
Metabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan, Taiwan.
6
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
7
Department of Thoracic and Cardiovascular Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
8
Clinical Metabolomics Core Laboratory, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
9
Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
10
Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan.
11
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.
12
Department & Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan.
13
Department of Life Sciences and Institute of Genome Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
14
Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
PMID:
35546525
PMCID:
PMC9210869
DOI:
10.2337/dc22-0145
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Letter
MeSH terms
Biomarkers
Diabetes Mellitus*
Diabetic Nephropathies*
Humans
Substances
Biomarkers
Associated data
ClinicalTrials.gov/NCT04839796